Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...

This was the stock's second consecutive day of losses.

Citigroup has recently reduced BIO-TECHNE Corp (TECH) stock to Neutral rating, as announced on May 22, 2024, according to Finviz. Earlier, on February 8, 2024, Scotiabank had initiated the stock to ...

Bio-Techne TECH is making notable strides in its ... The S&P 500 composite grew 32.4% in the same time frame. The renowned life sciences company has a market capitalization of $11.97 billion.

Bio-Techne Corp. closed $9.15 below its 52-week high ($85.57), which the company achieved on May 15th.

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...

Bio-Techne Corporation (NASDAQ ... However, this brings up another question – is now the right time to sell? If you believe TECH should trade below its current price, selling high and buying ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets.